Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

NCT02654158 is registered in ClinicalTrials.gov with Guangzhou Yipinhong Pharmaceutical CO.,LTD as lead sponsor.

NCT NCT02654158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
Lead sponsor
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
May 31, 2017
Enrollment
2,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory infection